Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 220,831,249 papers from all fields of science
Search
Sign In
Create Free Account
PEN 110
Known as:
PEN-110
, PEN110
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
Inactine
Broader (1)
Polyamines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents
V. Jayarama
,
J. Marcello
,
+5 authors
Aris Lazo
Transfusion
2006
Corpus ID: 10079331
BACKGROUND: Cytomegalovirus (CMV) is transmitted by transfusion of infected blood products and can cause serious diseases in…
Expand
2004
2004
Inactivation of mycoplasma species in blood by INACTINE PEN110 process
B. Zavizion
,
A. Purmal
,
J. Chapman
,
B. Alford
Transfusion
2004
Corpus ID: 11240483
BACKGROUND: Mycoplasmas have been associated with multiple acute and chronic diseases. Mycoplasma genome is found in the blood of…
Expand
2003
2003
Prevention of Yersinia enterocolitica, Pseudomonas fluorescens, and Pseudomonas putida outgrowth in deliberately inoculated blood by a novel pathogen‐reduction process
B. Zavizion
,
D. Serebryanik
,
I. Serebryanik
,
J. Chapman
,
A. Purmal
Transfusion
2003
Corpus ID: 36861912
BACKGROUND : Yersinia enterocolitica, Pseudomonas fluorescens, and P. putida are responsible for a significant amount of the…
Expand
Highly Cited
2002
Highly Cited
2002
Process for the preparation of pathogen‐inactivated RBC concentrates by using PEN110 chemistry: preclinical studies
A. Purmal
,
C. Valeri
,
+4 authors
J. Chapman
Transfusion
2002
Corpus ID: 2893306
BACKGROUND: A pathogen‐inactivation process for RBC concentrates is being developed by using PEN110 chemistry (INACTINE, V.I…
Expand
2002
2002
Broad‐spectrum virus reduction in red cell concentrates using INACTINE™ PEN110 chemistry
Aris Lazo
,
Jodie Tassello
,
+8 authors
J. Chapman
Vox Sanguinis
2002
Corpus ID: 26291887
Background and Objectives The risk of transmission of blood‐borne pathogens by transfusion is a persistent problem in medicine…
Expand
2002
2002
PEN110 treatment functionally inactivates the PBMNCs present in RBC units: comparison to the effects of exposure to gamma irradiation
L. Fast
,
G. DiLeone
,
C. Edson
,
A. Purmal
Transfusion
2002
Corpus ID: 10409023
BACKGROUND : The presence of WBCs in blood components is the major factor influencing the immunologic consequences of transfusion…
Expand
2002
2002
Production of pathogen‐inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study
J. AuBuchon
,
C. Pickard
,
+6 authors
Kathleen J. Beach
Transfusion
2002
Corpus ID: 39303879
BACKGROUND: Despite extensive reductions in risk, donor selection and testing cannot eliminate pathogen transmission. The…
Expand
2002
2002
Inactivation of HIV in blood
A. Ohagen
,
V. Gibaja
,
S. Aytay
,
J. Horrigan
,
Douglas Lunderville
,
Aris Lazo
Transfusion
2002
Corpus ID: 24807351
BACKGROUND : The residual risk of HIV infection after HIV screening tests in combination with the risk of new emerging pathogens…
Expand
2002
2002
Inhibition of murine GVHD by PEN110 treatment
L. Fast
,
G. DiLeone
,
C. Edson
,
A. Purmal
Transfusion
2002
Corpus ID: 24831503
BACKGROUND : The presence of WBCs in blood components is the primary factor influencing the immunologic consequences of…
Expand
Review
2000
Review
2000
Progress in improving the pathogen safety of red cell concentrates.
J. Chapman
Vox Sanguinis
2000
Corpus ID: 24614507
Current methods of preparing red cell concentrates do not include a process step to decontaminate pathogens potentially present…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE